• The work of one of the DEINOVE doctoral students, resulting from collaboration between DEINOVE and “UMR-MD1 TMCD2” laboratory (Aix-Marseille University) held the attention of the scientific committee of this prestigious conference. It was presented on April 30 as part of the "Multi-Drug Efflux Systems" session to an audience of scientists from around the world
  • This is recognition of the scientific quality of DEINOVE’s work, but also the relevance of the State’s support, which partially funds the Company's research through two CIFRE contracts , including that of doctoral student Erika Boulant via the ANRT 

DEINOVE (Alternext Paris: ALDEI), a biotech company developing innovative processes for producing biofuels and bio-based chemicals by using Deinococcus bacteria as host strains, today announced that one of its researchers, Erika Boulant, was selected by the scientific committee of the prestigious "Gordon Research Conference" to present her work as part of the "Multi-Drug Efflux Systems" session held in Barga, Italy, from April 26 to May 1, 2015 (https://www.grc.org/programs.aspx?id=13928).

The Gordon Research Conferences constitute an international forum for the presentation and discussion of frontier research in the biological, chemical, and physical sciences, and their related technologies. These scientific conferences were initiated by Johns-Hopkins University in the USA.
Erika Boulant's work focuses on the study of the mechanisms of resistance to fermentation products in Deinococcus. This is applied research to improve the performance of the strains. Erika joined the DEINOVE team as part of the CIFRE programme1 and works in the "UMR-MD1 Transporteurs Membranaires, Chimiorésistance et Drug-Design" laboratory in Marseille. She is one of the two researchers in the team who benefit from this type of state funding through the ANRT2.

"It is a pleasure and an honour to see the work of our young researchers recognised by a high-level organisation such as the Gordon Research Conferences. Erika's work is directly applicable to the improvement of a Deinococcus-based industrial production process", commented Jean-Paul Leonetti, VP of R&D at DEINOVE. "This is recognition of the quality of State-funded CIFRE contracts, which support this collaborative research project", added Jean-Michel Bolla, Team leader in Marseille.